Signal flow in the NMDA receptor-dependent phosphoproteome regulates postsynaptic plasticity for aversive learning.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: ppublish

Résumé

Structural plasticity of dendritic spines in the nucleus accumbens (NAc) is crucial for learning from aversive experiences. Activation of NMDA receptors (NMDARs) stimulates Ca

Identifiants

pubmed: 39255336
doi: 10.1126/scisignal.ado9852
doi:

Substances chimiques

Receptors, N-Methyl-D-Aspartate 0
Proteome 0
Nerve Tissue Proteins 0
rho-Associated Kinases EC 2.7.11.1
Phosphoproteins 0
Rho Guanine Nucleotide Exchange Factors 0
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado9852

Auteurs

Yasuhiro Funahashi (Y)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Rijwan Uddin Ahammad (RU)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Alzheimer's Therapeutic Research Institute, Keck School of Medicine of the University of Southern California, San Diego, CA 92121, USA.

Xinjian Zhang (X)

Division of Behavioral Neuropharmacology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Emran Hossen (E)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Masahiro Kawatani (M)

Department of Physiology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.

Shinichi Nakamuta (S)

Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Akira Yoshimi (A)

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, Nagoya, Aichi 468-8503, Japan.

Minhua Wu (M)

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Huanhuan Wang (H)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Mengya Wu (M)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Xu Li (X)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Md Omar Faruk (MO)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Md Hasanuzzaman Shohag (MH)

Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

You-Hsin Lin (YH)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Daisuke Tsuboi (D)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Tomoki Nishioka (T)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Keisuke Kuroda (K)

Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Mutsuki Amano (M)

Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Yukihiko Noda (Y)

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, Nagoya, Aichi 468-8503, Japan.

Kiyofumi Yamada (K)

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Kenji Sakimura (K)

Brain Research Institute, Niigata University, Niigata 951-8585, Japan.

Taku Nagai (T)

Division of Behavioral Neuropharmacology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Takayuki Yamashita (T)

Department of Physiology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
Division of Neurophysiology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Shigeo Uchino (S)

Department of Biosciences, School of Science and Engineering, Teikyo University, Utsunomiya, Tochigi 320-8551, Japan.

Kozo Kaibuchi (K)

Division of Cell Biology, International Center for Brain Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Center for Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH